<DOC>
	<DOCNO>NCT00150930</DOCNO>
	<brief_summary>UVB phototherapy commonly use treatment patient psoriasis . Generally perform outpatient department hospital . The UVB irradiation normally take minute , receive irradiation patient travel outpatient department work hour 2 3 time week . In general relatively time-consuming treatment . Objective study ass whether UVB treatment administer home equally effective standard outpatient UVB phototherapy . Quality life cost-effectiveness also study .</brief_summary>
	<brief_title>Home UVB Phototherapy Psoriasis : Effectiveness , Quality Life Cost-Effectiveness</brief_title>
	<detailed_description>Psoriasis chronic recurrent skin disorder characterise erythematosquamous lesion ( plaque ) . Usually abnormal area , occasionally disease generalise . Psoriasis treat locally application cream ointment , instance corticosteroid vitamin D3 . For patient topical therapy suffice . However , patient area involve topical application feasible . Or others , skin lesion respond anymore topical treatment . In case dermatologist may start irradiation ultraviolet ( UV ) light prescribe systemic medication . UVB phototherapy commonly use treatment patient psoriasis . Generally perform outpatient department hospital . The UVB irradiation normally take minute , receive irradiation patient travel outpatient department work hour 2 3 time week . In general relatively time-consuming treatment . To overcome drawback UVB treatment outpatient clinic , home UVB phototherapy introduce 25 year ago . However , safety effectiveness home UVB debate ever since . Despite discussion , number dermatologist prescribe home UVB phototherapy patient seem gradually increase . We recently demonstrate sound evidence would either support dissuade prescribe home UVB phototherapy . Particularly lack randomise research apparent . Therefore , objective study ass whether UVB treatment administer home equally effective standard outpatient UVB phototherapy . Quality life cost-effectiveness also study . Primary Outcome : ( SA ) PASI inclusion , start therapy , 23 ( 20-26 ) irradiation , end therapy , every 2 month end therapy ( maximum 1 year ) Quality life score ( EQ-5D , SF-36 , PDI ) inclusion , start therapy , 23 ( 20-26 ) irradiation end therapy . Costs Cost-Effectiveness calculated time-horizon 12 month inclusion ( questionnaire use inclusion , start therapy , 23 ( 20-26 ) irradiation , end therapy , every 2 month end therapy ( maximum 1 year ) ) Secondary Outcome : Cumulative dosimetry ( every irradiation ) Total amount type side-effects ( every irradiation ) Concomitant use medication ( whole trial , data derive patient ' pharmacist )</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>1 . Guttate plaque psoriasis , clinically eligible narrowband UVB ( TL01 ) phototherapy ; 2 . Willing undergo treatment accord randomisation . Exclusion criterion : 1 . No informed consent : age 18 year ; willing accept one two treatment offer ; 2 . Practical reason : able receive one two treatment offer ( e.g . lack space home / live far hospital etc . ) ; analphabetism ( unable read patientinformation questionnaire , unable provide write answer write informed consent ) ; lack knowledge Dutch language ; possession telephone . 3 . Expected noncompliance : lack understand study / treatment , potential consequence . 4 . Medical contraindication : malignancy skin past / present ; know UVBallergy chronic polymorphic photodermatosis ; use ( time inclusion ) ( systemic ) medication know phototoxic photoallergic property ; use ( time inclusion ) systemic antipsoriatic medication ( cyclosporin , methotrexate , neotigason , fumaric acid ) ; history exposure ionise radiation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>ultraviolet</keyword>
	<keyword>UVB</keyword>
	<keyword>phototherapy</keyword>
	<keyword>home care</keyword>
	<keyword>narrowband</keyword>
</DOC>